Morning Overview on MSN
CBD just calmed the brain’s own immune cells in a new lab study — quietly pulling the plug on the inflammation that drives Alzheimer’s disease
More than 55 million people worldwide live with dementia, and Alzheimer’s disease accounts for the majority of cases. Despite ...
Morning Overview on MSN
USC just pinned down the hidden enzyme driving Alzheimer’s brain inflammation — and found a compound that crosses the blood-brain barrier to shut it down
For decades, researchers have watched anti-inflammatory drugs fail against Alzheimer’s disease, unable to explain why ...
Alzheimer’s doesn’t begin with memory loss. It starts decades earlier. New research reveals that a simple trace mineral may ...
The data shows that immune cells converge at sites of motor neuron loss and TDP-43 pathology with distinct patterns depending ...
Novel inflammatory markers like SII, NLR, and SIRI may predict OAB prevalence and risk, highlighting systemic inflammation's role in OAB pathophysiology. A study of 19,194 participants found ...
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, remains a major clinical challenge owing to its complex pathophysiology and clinical management: it is a ...
When it comes to the most common mental health issues, we’ve long overemphasized the role of neurotransmitters like serotonin and dopamine. Recently, especially in the case of depression and serotonin ...
A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...
Data highlight both SER-603’s rational design that targets microbial functions linked to mucosal healing and gastrointestinal inflammation in IBD, as well as the advancement of microbiome-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results